Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-24

Clinical Trial Update: ATCF (Azole Therapy in Cystic Fibrosis) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of azole therapy in cystic fibrosis patients with Aspergillus infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azole Therapy (azole antifungal)

Snippet

Sponsor: Rennes University Hospital | Conditions: Cystic Fibrosis, Aspergillus Infections | Phase 2 | Status: COMPLETED